Fawaz Aswad

Fawaz Aswad

Auto-generated profile, based on publicly available information

Fawaz Aswad

Department of Oral Medicine, Dentistry College at Baghdad University, Baghdad, Iraq

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2022 in Health Science Reports
Verified
Journal Article
Open access
MAMuhanad L. Alshami
Muhanad L. Alshami
FAFawaz Aswad
Fawaz Aswad
BABashar Abdullah
Bashar Abdullah
Background and Aims: Pemphigus vulgaris is an autoimmune vesiculobullous mucocutaneous disorder with life‐threatening consequences. Early detection and adequate care are crucial for a good prognosis. This study aimed to determine the demographic data, clinical features, and the prognosis of patients with oral pemphigus vulgaris.Materials and Methods: From 2001 to 2021, all diagnosed oral pemphigus vulgaris cases were extracted. Each patient's demographic and clinical data were gathered. Patients were called via phone to assess the prognosis, treatment type, and specialty of the physician who provided the diagnosis and therapy.Results: The majority of the patients had only oral lesions with higher prevalence in female who also expressed severe pain than male. Only 14 of 29 patients responded phone calls. Except for one, all patients were in active disease. More than half of those respondents said pemphigus negatively affects social behavior and food intake. Correct diagnosis and treatment were decided by dermatology, oral medicine, and maxillofacial surgery specialists.Conclusion: Oral pemphigus vulgaris was prevalent in females. Severe pain was common in females and older people. Even with effective therapy, the prognosis was poor. Medical and dental professionals had little knowledge of pemphigus vulgaris. Patients frequently report poor quality of life.

31 January 2025 in Wiadomości Lekarskie
Verified
Journal Article
Closed access
RHRana Murtadha Hasan
Rana Murtadha Hasan
ADAmeena Ryhan Diajil
Ameena Ryhan Diajil
NANoor Mohammed Ali
Noor Mohammed Ali
FAFawaz Aswad
Fawaz Aswad
LTLina Ziyad Tariq
Lina Ziyad Tariq
Aim: Background: Temporomandibular disorder is characterized by clinical indications and symptoms affecting masticatory muscles and associated tissues. It does not affect individuals equally, and not everyone is equally susceptible to it. Aims: The study aims mainly to evaluate the symptoms and indicators that people with TMD experience and encourage them to seek treatment at an academic oral medicine clinic.Material and methods: Materials and Methods: The study includes temporomandibular joint patients who visited the oral medicine clinic at the University of Baghdad's College of Dentistry between October 2021 and May 2022. The information was gathered from temporomandibular joint patients' medical records.Results: Result: In the research herein, 323 patients in total were included, females 234(72.4%) and 89(27.6%) males, the patient's mean age was (31.38 ± 14.085), and there was no discernible gender difference in mean age. In this study, the most prevalent temporomandibular joint signs and symptoms were temporomandibular joint clicking 73.6% with no significant difference between females and males. In comparison, dislocation is the least prevalent and the most prevalent muscle spasm was the masseter muscle with a percentage of 50.4%) while the sternocleidomastoid muscle is the least one.Conclusions: Conclusion: The research results demonstrated a significant prevalence of temporomandibular joint disorder and the necessity of preventing it to improve the overall well-being of people in general.

15 June 2026 in Journal of Baghdad College of Dentistry
Verified
Journal Article
Open access
MMMeena Muneeb
Meena Muneeb
FAFawaz D Aswad
Fawaz D Aswad
MNMuzzammil Nusrath
Muzzammil Nusrath
Background: This study aimed to assess the impact of topical kappa- carrageenan gel on alleviating Burning Mouth Syndrome (BMS) symptoms in type 2 diabetic patients and to assess its impact on salivary immunoglobulin A (IgA) and alpha-amylase levels. Material and methods: 156 participants were included: 104 type 2 diabetic patients with BMS (52 males, 52 females) and 52 healthy controls. Diabetes diagnosis was confirmed through fasting blood glucose and HbA1c tests. BMS diagnosis was established clinically, using criteria and laboratory tests to exclude other causes. Kappa carrageenan gel was prepared and applied topically to relieve BMS symptoms. Unstimulated whole saliva samples were collected to measure salivary IgA and alpha-amylase levels using enzyme-linked immunosorbent assay. The collection of saliva was conducted at two different time points for the BMS group and once for the controls. Results: Application of carrageenan gel showed no significant effect on salivary IgA levels in diabetic BMS patients. However, there was a significant reduction in salivary alpha-amylase levels after carrageenan gel application, indicating a possible response to treatment. Conclusions: Kappa carrageenan gel may serve as a potential therapeutic option for relieving the burning sensation and pain associated with BMS in patients with type 2 diabetes. While the gel did not influence IgA levels, the significant reduction in salivary alpha-amylase suggests an impact on stress-related salivary biomarkers, supporting its symptomatic relief potential in managing BMS in diabetic patients.

4 September 2024 in South Eastern European Journal of Public Health
Verified
Journal Article
Open access
PDF file
HAHasnaa Jameel Sharrad Alhuseiny
Hasnaa Jameel Sharrad Alhuseiny
FAFawaz Dawood Al-Aswad
Fawaz Dawood Al-Aswad
BABalsam Saadi Abdulhameed
Balsam Saadi Abdulhameed
TAThaer Hameed Mohsin Almayyahi
Thaer Hameed Mohsin Almayyahi
MAMuayed S Al-Huseiny
Muayed S Al-Huseiny
AAAhmed Sattar Sajit Alhuseiny
Ahmed Sattar Sajit Alhuseiny
Introduction: Assessing occlusion and TMJ discrepancies presents a persistent challenge for health professionals due to the complexity of the conditions that include accurate: diagnostic methods, treatment, associated comorbidities. Researches are being delved in this field. Cadiax Compact II is one of the technological innovations that can analyze and provide a simple and minimally invasive way, enabling early preventive action and treatment with a long-term impact on the good functioning of the masticatory system. Objectives: The objective of this research is to evaluate TMJ changes among dental implant patients. A comparison of the implant impact on posterior partial edentulous patient is taken place by the aid of Cadiax Compact II. Cadiax Compact II investigates in parameters such as Immediate Side-Shift (ISS), Sagittal Condylar Guidance (SCG), and Transverse Condylar Guidance (TCG) that are derived from mandible movements (opening, closing, protrusion, retrusion, and lateral excursion). The objective is to evaluate the changes in TMJ before and after implants in partial edentulous (posterior teeth) patients. Methods: Condylography using Cadiax Compatct II device (Gamma Dental, Klosterneuburg, Austria) was conducted on 40 patients. R statistical software was used to perform statistical analysis to perform a cephalometric analysis. Results: Age groups covered are (<40), (40-49), (50-59), and (≥ 60). Alpha value, level of uncertainty, was chosen to be 0.05. There is no statistical evidence in the change of ISS, SCG, and TCG before and after implant in the age groups (<40) and (40-49); however, there is a significant statistical change in age groups (50-59) and (≥ 60) with p-value <0.05. Conclusions: This research extended from December 2022 to March 2024 to cover time changes on mandible bone structure. The research outcomes revealed that implant has pronounced impact on TMJ articulation during opening, protrusion, retrusion, and lateral movements through (ISS, SCG, and TCG or so-called Bennet Angle) variables. Evidence-based statical tests with p-value < 0.05 showed that (ISS, SCG, TCG, and Bennet Angle) variables changed in age groups (50-59) and (≥ 60) from abnormal ranges to the normal ranges after implant. However, no statistical evidence was approved of the implant impact on age groups (<40) and (40-49). Though these age groups have normal ranges before and after implants.